I. Gath et al., Analysis of NO synthase expression in neuronal, astroglial and fibroblast-like derivatives differentiating from PCC7-Mz1 embryonic carcinoma cells, EUR J CELL, 78(2), 1999, pp. 134-142
We studied the expression of the NO synthase isoforms in an in vitro model
of neural development using RT-PCR, Western blot and immunohistochemistry.
Murine PCC7-Mz1 cells (Jostock et al,, Eur. J. Cell Biol, 76, 63-76, 1998)
differentiate in the presence of all-trans retinoic acid and dibutyryl cAMP
along the neural pathway into neuron-like, fibroblast-like and astroglia-l
ike cells. Undifferentiated cells showed immunofluorescent staining for neu
ronal-type NOS I and endothelial-type NOS III. This expression pattern was
retained in those cells differentiating into neurofilament- and tau protein
-positive neuronal cells. Thymocyte alloantigen (Thyl.2/CD 90.2)-positive f
ibroblasts, appearing around day 3, and glial fibrillary acidic protein (GF
AP)-positive astroglial cells, appearing after day 6 of differentiation, st
ained negative for any NOS isoform, Starting at day 6 of differentiation, e
xpression of inducible-type NOS II could be stimulated with cytokines in a
subset of cells, which may represent activated astrocytes, NOS II was alway
s undetectable in non-induced cultures. These data indicate that the abilit
y of stem cells to express NOS I and NOS III is only retained when the cell
s differentiate along the neuronal lineage, while a small subpopulation of
cells acquires the ability to express NOS II in response to cytokines.